首页> 美国卫生研究院文献>Cancer Science >Hepatocellular Tumorigenicity of Butylated Hydroxytoluene Administered Orally to B6C3F1 Mice
【2h】

Hepatocellular Tumorigenicity of Butylated Hydroxytoluene Administered Orally to B6C3F1 Mice

机译:口服给予B6C3F1小鼠的丁基化羟基甲苯的肝细胞致瘤性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Butylated hydroxytoluene (BHT), a preservative widely found in food as a food additive, was orally administered at concentrations of 1% and 2% of the diet to B6C3F1 mice for 104 consecutive weeks. Treated animals underwent a 16‐week recovery period prior to pathological examination. In male mice administered BHT, the incidence of mice with either a hepatocellular adenoma or a focus of cellular alteration in the liver was increased in a clear dose‐response relationship. The incidences of male mice with other tumors and the incidences of female mice with any tumor were not significantly increased as a consequence of BHT administration. The results of this study indicate BHT to be tumorigenic to the liver of the B6C3F1 male mouse.
机译:丁基化羟基甲苯(BHT)是在食品中广泛用作食品添加剂的防腐剂,已连续104周以1%和2%的饮食浓度向B6C3F1小鼠口服给药。在进行病理检查之前,经过治疗的动物要经过16周的恢复期。在服用BHT的雄性小鼠中,肝细胞性腺瘤或肝脏细胞改变灶的小鼠的发病率以明确的剂量反应关系增加。 BHT给药的结果是,患有其他肿瘤的雄性小鼠的发病率和患有任何肿瘤的雌性小鼠的发病率均未显着增加。这项研究的结果表明BHT对B6C3F1雄性小鼠的肝脏具有致瘤性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号